Bank of America’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-2,789
| Closed | -$10.9K | – | 7302 |
|
|
2023
Q3 | $10.9K | Buy |
2,789
+2,774
| +18,493% | +$10.9K | ﹤0.01% | 5924 |
|
|
2023
Q2 | $49 | Sell |
15
-2,526
| -99% | -$8.25K | ﹤0.01% | 6571 |
|
|
2023
Q1 | $9.15K | Buy |
2,541
+1,577
| +164% | +$5.68K | ﹤0.01% | 6116 |
|
|
2022
Q4 | $31K | Sell |
964
-1,471
| -60% | -$47.4K | ﹤0.01% | 5826 |
|
|
2022
Q3 | $102K | Buy |
2,435
+1,023
| +72% | +$42.9K | ﹤0.01% | 5522 |
|
|
2022
Q2 | $59K | Buy |
1,412
+604
| +75% | +$25.2K | ﹤0.01% | 5966 |
|
|
2022
Q1 | $55K | Sell |
808
-906
| -53% | -$61.7K | ﹤0.01% | 6353 |
|
|
2021
Q4 | $208K | Buy |
1,714
+1,366
| +393% | +$166K | ﹤0.01% | 5673 |
|
|
2021
Q3 | $49K | Buy |
348
+16
| +5% | +$2.25K | ﹤0.01% | 6175 |
|
|
2021
Q2 | $91K | Sell |
332
-1,303
| -80% | -$357K | ﹤0.01% | 5770 |
|
|
2021
Q1 | $350K | Buy |
1,635
+1,285
| +367% | +$275K | ﹤0.01% | 5017 |
|
|
2020
Q4 | $85K | Buy |
350
+135
| +63% | +$32.8K | ﹤0.01% | 5331 |
|
|
2020
Q3 | $23K | Sell |
215
-44
| -17% | -$4.71K | ﹤0.01% | 5597 |
|
|
2020
Q2 | $25K | Buy |
259
+90
| +53% | +$8.69K | ﹤0.01% | 5619 |
|
|
2020
Q1 | $13K | Sell |
169
-202
| -54% | -$15.5K | ﹤0.01% | 5683 |
|
|
2019
Q4 | $30K | Buy |
371
+8
| +2% | +$647 | ﹤0.01% | 5579 |
|
|
2019
Q3 | $45K | Buy |
363
+70
| +24% | +$8.68K | ﹤0.01% | 5527 |
|
|
2019
Q2 | $52K | Buy |
293
+147
| +101% | +$26.1K | ﹤0.01% | 5510 |
|
|
2019
Q1 | $22K | Sell |
146
-199
| -58% | -$30K | ﹤0.01% | 5714 |
|
|
2018
Q4 | $90K | Buy |
345
+293
| +563% | +$76.4K | ﹤0.01% | 5233 |
|
|
2018
Q3 | $13K | Buy |
52
+19
| +58% | +$4.75K | ﹤0.01% | 5856 |
|
|
2018
Q2 | $8K | Buy |
+33
| New | +$8K | ﹤0.01% | 5968 |
|